Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0007 USD | 0.00% | 0.00% | -99.98% |
2023 | Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. | CI |
2023 | Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index | CI |
Business Summary
Number of employees: 46
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Toll-like Receptors
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +465.54% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 81.2 % | 1 | 100.0 % | +596.47% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yakov Kogan
FOU | Founder | 50 | 04/06/03 |
Andrei V. Gudkov
FOU | Founder | 66 | 04/06/03 |
Michael Handley
CEO | Chief Executive Officer | 52 | 26/07/21 |
Christopher Zosh
DFI | Director of Finance/CFO | 48 | 31/05/14 |
Allie Lopez
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/20 |
James Mendolera
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/21 |
Chief Tech/Sci/R&D Officer | 63 | 26/07/21 | |
George Wagner
LAW | General Counsel | - | - |
Curt Dewitz
PRN | Corporate Officer/Principal | - | 29/02/20 |
Todd Headley
PRN | Corporate Officer/Principal | - | 31/12/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John A. Kallassy
BRD | Director/Board Member | 59 | 01/09/22 |
Uday Saxena
BRD | Director/Board Member | 66 | 16/06/22 |
Michael Handley
CEO | Chief Executive Officer | 52 | 26/07/21 |
Director/Board Member | 68 | 23/02/22 | |
Director/Board Member | 59 | 16/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 71,416,038 | 71,416,038 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Statera Biopharma, Inc.
4333 Corbett Drive Suite 1082
80525, Fort Collins
+888 613 8802
http://www.staterabiopharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- STAB Stock
- STAB Stock
- Company Statera Biopharma, Inc.